Ariel Investments, LLC Astrazeneca PLC Transaction History

Ariel Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $18,865 - $24,513	348 Added 1.58%	22,396 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $33,720 - $86,337	-636 Reduced 2.8%	22,048 $1.21 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $74,608 - $89,565	-1,259 Reduced 5.26%	22,684 $1.5 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $44,353 - $53,427	-796 Reduced 3.22%	23,943 $1.59 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $86,864 - $102,638	-1,608 Reduced 6.1%	24,739 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $4,167 - $4,559	-75 Reduced 0.28%	26,347 $1.58 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $17,818 - $22,146	-368 Reduced 1.37%	26,422 $1.58 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $18,156 - $20,959	385 Added 1.46%	26,790 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $1.28 Million - $1.53 Million	26,405 New	26,405 $1.32 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Ariel Investments, LLC with notifications on news.